Misonix receives FDA 510(k) OK for laparoscopic HIFU product
Published: Jan 30, 2006 12:48 p.m. ET
SAN FRANCISCO (MarketWatch) -- Misonix Inc. MSON, -0.26% said Monday the Food and Drug Administration has granted 510(k) clearance for the company to market and sell its Sonatherm 600 Ultrasonic Lesion Generating System in the United States. The device is used for the ablation of certain soft tissue lesions in general surgery procedures, and is based on its high intensity focused ultrasound technology licensed from Focus Surgery, the Farmingdale, N.Y.-based company said.
Misonix Inc. U.S.: Nasdaq: MSON
Market Cap 297.6M